Developments in Nuclear Medicine

PET for Drug Development and Evaluation

Editors: Comar, D. (Ed.)

Buy this book

eBook $199.00
price for USA (gross)
  • ISBN 978-94-011-0429-6
  • Digitally watermarked, DRM-free
  • Included format: PDF
  • ebooks can be used on all reading devices
  • Immediate eBook download after purchase
Hardcover $359.00
price for USA
  • ISBN 978-0-7923-3716-4
  • Free shipping for individuals worldwide
  • Usually dispatched within 3 to 5 business days.
Softcover $259.00
price for USA
  • ISBN 978-94-010-4191-1
  • Free shipping for individuals worldwide
  • Usually dispatched within 3 to 5 business days.
About this book

Can drug development and evaluation be improved by the use of positron emission tomography (PET)? PET is now well established and many PET centres participate in networks that warrant the quality of their research. PET allows one to follow the effect of a drug on a variety of patients' metabolic parameters. In addition, PET may be used to follow the fate in vivo of a compound, allowing visualisation of its binding to specific receptors and a direct study of the mechanism of drug action in normal and pathological situations.
The book shows the fields in which PET offers new and unique information for the development of drugs (conception, toxicity, pharmacokinetics and metabolism, clinical research, and relations between clinical and biological effects) and evaluates fields in which PET may shorten the development time of drugs.
Audience: Professionals in the pharmaceutical industry in all areas of drug discovery and pharmacology, pre-clinical testing, pharmacokinetics and metabolism, clinical evaluation, registration and regulatory affairs. Government health authority representatives who assess data and documentation on new drug development and radiopharmaceuticals. Academic experts concerned with any of these areas.

Table of contents (31 chapters)

  • Drug Development and Positron Emission Tomography

    Campbell, Bruce

    Pages 1-24

  • Positron Emission Tomography: Basic Principles and Potential Interest for Pharmacological Studies

    Mazoyer, Bernard

    Pages 25-35

  • Is PET a Tool for Drug Evaluation?

    Långström, Bengt (et al.)

    Pages 37-50

  • PET in Neuropsychiatric Drug Development

    Farde, Lars

    Pages 51-53

  • Radioligand Disposition and Metabolism — Key Information in Early Drug Development

    Halldin, Christer (et al.)

    Pages 55-65

Buy this book

eBook $199.00
price for USA (gross)
  • ISBN 978-94-011-0429-6
  • Digitally watermarked, DRM-free
  • Included format: PDF
  • ebooks can be used on all reading devices
  • Immediate eBook download after purchase
Hardcover $359.00
price for USA
  • ISBN 978-0-7923-3716-4
  • Free shipping for individuals worldwide
  • Usually dispatched within 3 to 5 business days.
Softcover $259.00
price for USA
  • ISBN 978-94-010-4191-1
  • Free shipping for individuals worldwide
  • Usually dispatched within 3 to 5 business days.
Loading...

Recommended for you

Loading...

Bibliographic Information

Bibliographic Information
Book Title
PET for Drug Development and Evaluation
Editors
  • D. Comar
Series Title
Developments in Nuclear Medicine
Series Volume
26
Copyright
1995
Publisher
Springer Netherlands
Copyright Holder
Springer Science+Business Media Dordrecht
eBook ISBN
978-94-011-0429-6
DOI
10.1007/978-94-011-0429-6
Hardcover ISBN
978-0-7923-3716-4
Softcover ISBN
978-94-010-4191-1
Edition Number
1
Number of Pages
VIII, 360
Topics